Topiramate Nephrolithiasis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Cystine
Topiramate inhibits carbonic anhydrase in the renal tubule, causing metabolic acidosis, alkaline urine, and reduced urinary citrate excretion. This predisposes to calcium phosphate stone formation (not calcium oxalate or uric acid). The risk is dose-dependent. Patients on topiramate should maintain adequate hydration. Calcium phosphate stones are radiopaque, but the question states radiolucent – in practice topiramate stones can be mixed composition. Nonetheless, calcium phosphate is the characteristic association.
Reference: AMH – 2025 – Topiramate; eTG – 2025 – Nephrology